Intraocular transplantation of encapsulated cells
US6663894B2 · kind B2 · utility
3Cited by
3References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 1, 2001 |
| Grant date | Dec 16, 2003 |
| Priority date | — |
| Expiry date | Feb 1, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0051
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.